Pacira BioSciences Inc. – Filings and Transcripts

NASDAQ: PCRX
Share price (10/7/26): $25.20
Market cap (10/7/26): $1.005 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Info about tender offer or issuer

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Slonin Jonathan

Slonin Jonathan

State Street Corporation

News Filter

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

Reports Second Quarter 2026 Financial Results

Announces Agreement to Divest Its Iovera° Business to Zimmer Biomet

Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting

Reports First Quarter 2026 Financial Results

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Proxy materials by non-management

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC